IPSC Century Therapeutics, Inc.

NASDAQ
$1.37

Century Therapeutics, Inc. (IPSC) is expected to report earnings on February 11, 2027, after the market close. The consensus earnings estimate is a loss of $0.12 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -21.7% since its last earnings release on November 12, 2026.

Century Therapeutics, Inc. Beat Consensus Estimates
Thursday, November 12, 2026 · 7:05 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · After Close
Earnings Whisper
-
vs ($0.12)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.57

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Century Therapeutics, Inc.

Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.